Media Statements

Ipsen media statements for investors and members of the press.

Key highlights

Explore more statements

Filter

Topics

Period

Filter by

recent search

Showing: 104 of 4 Media Statements

Ipsen CEO David Loew is elected to EFPIA leadership; joins industry partners to warn of impact of EU pharma legislation
Ipsen CEO David Loew is elected to EFPIA leadership; joins industry partners to warn of impact of EU pharma legislation

On Wednesday 21 June, David Loew was elected second Vice President of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Yesterday’s appointments also included Lars Fruergaard Jørgensen, Chief Executive of Novo Nordisk, as EFPIA President, and Stefan Oelrich, Head…


Ipsen and Medetia join forces to accelerate early research in rare disease

Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges
Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges

Ipsen is committed to bringing innovative medicines to the rare disease community where a significant unmet need exists and innovation in treatments is lacking.


Offering support to those impacted in Turkey & Syria
Offering support to those impacted in Turkey & Syria

We are deeply saddened by the tragic earthquake across Turkey and Syria and the worsening humanitarian crisis. Our thoughts are with all of those impacted by the devastating events and our gratitude to those who are bravely leading the rescue…


Your dedicated contacts